Effect	NN
of	IN
glycosides	NNS
based	VBN
standardized	JJ
fenugreek	NN
seed	NN
extract	NN
in	IN
bleomycin-induced	JJ
pulmonary	JJ
fibrosis	NN
in	IN
rats	NNS
:	:
Decisive	JJ
role	NN
of	IN
Bax	NN
,	,
Nrf2	NN
,	,
NF-kB	NN
,	,
Muc5ac	NN
,	,
TNF-a	NN
and	CC
IL-1b	NN
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
progressive	JJ
multifactorial	JJ
disease	NN
with	IN
limited	JJ
therapeutic	JJ
options	NNS
.	.

Glycosides	NNS
based	VBN
standardized	JJ
fenugreek	NN
seed	NN
extract	NN
(	(
SFSE-G	NN
)	)
possesses	VBZ
potent	JJ
anti-inflammatory	JJ
and	CC
anti-oxidant	JJ
property	NN
.	.

AIM	NN
:	:
To	TO
evaluate	VB
the	DT
efficacy	NN
of	IN
SFSE-G	NN
against	IN
bleomycin	NN
(	(
BLM	NN
)	)
induced	VBD
pulmonary	JJ
fibrosis	NN
by	IN
assessing	VBG
behavioral	JJ
,	,
biochemical	JJ
,	,
molecular	JJ
and	CC
ultrastructural	JJ
changes	NNS
in	IN
the	DT
laboratory	NN
rats	NNS
.	.

MATERIALS	NNS
AND	CC
METHODS	NNS
:	:
IPF	NN
was	VBD
induced	VBN
in	IN
male	JJ
Sprague-Dawley	JJ
rats	NNS
by	IN
single	JJ
intratracheal	JJ
BLM	NN
(	(
6IU/kg	NN
)	)
injection	NN
followed	VBN
by	IN
SFSE-G	NN
(	(
5	CD
,	,
10	CD
,	,
20	CD
and	CC
40mg/kg	CD
,	,
p.o.	NN
)	)
or	CC
methylprednisolone	NN
(	(
10mg/kg	NN
,	,
p.o.	NN
)	)
treatment	NN
for	IN
28day	NN
.	.

Various	JJ
parameters	NNS
were	VBD
analyzed	VBN
in	IN
lung	NN
and	CC
bronchoalveolar	JJ
lavage	NN
fluid	NN
(	(
BALF	NN
)	)
after	IN
14	CD
and	CC
28days	NNS
of	IN
the	DT
drug	NN
treatment	NN
.	.

RESULTS	NNS
:	:
SFSE-G	NN
(	(
20	CD
and	CC
40mg/kg	CD
,	,
p.o.	NN
)	)
administration	NN
significantly	RB
prevented	VBD
the	DT
BLM	NN
induced	VBD
alteration	NN
in	IN
body	NN
weight	NN
,	,
lung	NN
index	NN
,	,
lung	NN
function	NN
test	NN
and	CC
hematology	NN
.	.

The	DT
altered	JJ
total	NN
and	CC
differential	JJ
cell	NN
count	NN
in	IN
BALF	NN
and	CC
blood	NN
was	VBD
significantly	RB
prevented	VBN
by	IN
SFSE-G	NN
treatment	NN
.	.

The	DT
decreased	VBN
peripheral	JJ
blood	NN
oxygen	NN
content	NN
after	IN
BLM	NNP
instillation	NN
was	VBD
significantly	RB
increased	VBN
by	IN
SFSE-G	NN
treatment	NN
.	.

SFSE-G	NN
significantly	RB
enhanced	VBD
the	DT
BALF	NN
and	CC
lung	NN
antioxidant	JJ
status	NN
,	,
through	IN
modulating	VBG
the	DT
SOD	NN
,	,
GSH	NN
,	,
T-AOC	NN
,	,
MDA	NNP
,	,
NO	DT
level	NN
and	CC
Nrf2	NN
,	,
HO-1	NN
mRNA	NN
expression	NN
.	.

There	EX
was	VBD
a	DT
significant	JJ
reduction	NN
in	IN
lung	NN
5-HT	NN
level	NN
by	IN
SFSE-G	NN
treatment	NN
.	.

The	DT
altered	JJ
mRNA	NN
expression	NN
of	IN
biomarkers	NNS
of	IN
lung	NN
inflammation	NN
(	(
TNF-a	NN
,	,
IL-1b	NN
,	,
IL-6	NN
and	CC
IL-8	NN
)	)
,	,
fibrosis	NN
(	(
TGF-b	NN
,	,
collagen-1	NN
,	,
ET-1	NN
,	,
Muc5ac	NN
,	,
NF-kB	NN
,	,
VEGF	NN
,	,
Smad-3	NN
)	)
and	CC
apoptosis	NN
(	(
Bax	NN
,	,
Bcl-2	NN
and	CC
Caspase-3	NN
)	)
were	VBD
significantly	RB
prevented	VBN
by	IN
SFSE-G	NN
treatment	NN
.	.

BLM	NN
induced	VBD
histological	JJ
inflammatory	JJ
and	CC
fibrotic	JJ
insult	NN
in	IN
the	DT
lung	NN
were	VBD
reduced	VBN
by	IN
SFSE-G	NN
treatment	NN
.	.

It	PRP
also	RB
ameliorated	VBD
BLM	NNP
induced	VBD
lung	NN
ultrastructural	JJ
changes	NNS
as	IN
observed	VBN
by	IN
transmission	NN
electron	NN
microscopic	JJ
studies	NNS
.	.

However	RB
,	,
administration	NN
of	IN
SFSE-G	NN
(	(
5mg/kg	NN
,	,
p.o.	NN
)	)
failed	VBD
to	TO
show	VB
any	DT
protective	JJ
effect	NN
against	IN
BLM-induced	JJ
PF	NN
whereas	IN
SFSE-G	NN
(	(
10mg/kg	NN
,	,
p.o.	NN
)	)
showed	VBD
significant	JJ
amelioration	NN
in	IN
BLM-induced	JJ
PF	NN
except	IN
lung	NN
function	NN
test	NN
,	,
BALF	NN
and	CC
lung	NN
antioxidant	JJ
level	NN
.	.

CONCLUSION	NN
:	:
SFSE-G	NN
showed	VBD
anti-fibrotic	JJ
efficacy	NN
executed	VBN
through	IN
induction	NN
of	IN
Nrf2	NN
,	,
which	WDT
in	IN
turn	NN
may	MD
modulate	VB
anti-inflammatory	JJ
molecules	NNS
,	,
inhibit	VBP
fibrogenic	JJ
molecules	NNS
and	CC
decreased	VBD
apoptosis	NN
to	TO
ameliorate	VB
BLM	NN
induced	VBN
pulmonary	JJ
fibrosis	NN
.	.

